Innate immunity based cancer immunotherapy: B16-F10 murine melanoma model

BACKGROUND: Using killed microorganisms or their parts to stimulate immunity for cancer treatment dates back to the end of 19(th) century. Since then, it undergone considerable development. Our novel approach binds ligands to the tumor cell surface, which stimulates tumor phagocytosis. The therapeut...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Main Authors: Caisová, Veronika, Vieru, Andra, Kumžáková, Zuzana, Glaserová, Simona, Husníková, Hana, Vácová, Nikol, Krejčová, Gabriela, Paďouková, Lucie, Jochmanová, Ivana, Wolf, Katherine I., Chmelař, Jindřich, Kopecký, Jan, Ženka, Jan
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2016
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5142338/
https://ncbi.nlm.nih.gov/pubmed/27927165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2982-x
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares